Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Health in Duchenne Muscular Dystrophy – randomized controlled study of risedronate
2009-017649-67Phase 2Completed
- Sponsor
- Central Remedial Clinic
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of risedronate in Duchenne muscular dystrophy (DMD), osteopenia and osteoporosis (2 arms), sponsored by Central Remedial Clinic. Primary endpoint: Bone health outcomes. Started Jan 2010; status: completed.
02
Drugs
risedronate
03
Conditions
Duchenne muscular dystrophy (DMD)osteopeniaosteoporosis
Beyond the preview
Go deeper on 2009-017649-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017649-67.